Enliven Therapeutics, Inc. ($ELVN)
Filing Information
| Accession Number | 0001701247-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | May 20, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
15,000
Total Value
$211,371.39
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF MEDICAL OFFICER | Common Stock | โ | May 18, 2026 | Exercise/Conversion | 5,000 | $2.48 | $12,400.00 | 30,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 18, 2026 | Sale | 3,475 | $39.53 | $137,380.65 | 26,525 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 18, 2026 | Sale | 1,302 | $40.25 | $52,401.98 | 25,223 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Common Stock | โ | May 18, 2026 | Sale | 223 | $41.21 | $9,188.76 | 25,000 | Direct | โ | View Details | |
CHIEF MEDICAL OFFICER | Stock Option (right to buy) | Derivative | May 18, 2026 | Exercise/Conversion | 5,000 | $0.00 | $0.00 | 126,268 | Direct | โ | View Details |